Maternal treatment with dexamethasone at minimal therapeutic doses inhibits neonatal bone development in a gender-dependent manner

Livestock Science

Volumn 146, Issue 2-3, 2012, Pages 175-182

  Tomaszewska, Ewa ^a   Dobrowolski, Piotr ^b   Siwicki, Andrzej ^c  

^a UNIVERSITY OF LIFE SCIENCES IN LUBLIN   (Poland)

^b MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

^c UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

Author keywords

Bone; Dexamethasone; Gender; Histomorphometry; Piglets

Indexed keywords

SUIDAE;

EID: 84860428589     PISSN: 18711413     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.livsci.2012.03.008     Document Type: Article

References (36)

1. Banjanin S., Kapoor A., Matthews S.G. Prenatal glucocorticoid exposure alters hypothalamic-pituitary-adrenal function and blood pressure in mature male guinea pigs. J. Physiol. 2004, 558.1:305-318.
2. Barbazanges A., Piazza P.V., Le Moal M., Maccari S. Maternal glucocorticoid secretion mediates long-term effects of prenatal stress. J. Neurosci. 1996, 16:3943-3949.
3. Boisen S. Ideal dietary amino acids profiles for pigs. Amino Acids in Animal Nutrition 2003, 157-169. CAB International, Cambridge, USA. 2nd ed. J.P.F. D'Mello (Ed.).
4. Carroll J.A. Dexamethasone treatment at birth enhances neonatal growth in swine. Domest. Anim. Endocrinol. 2001, 21:97-109.
5. Duee P.-H., Pegorier J.-P., Darey-Vrillon B., Girard J. Glucose and fatty acid metabolism in the newborn pig. Advances in Swine in Biomedical Research 1996, 865-885. Plenum Press, New York, USA. M.E. Tumbleson, L.B. Schook (Eds.).
6. Ferretti J.L., Capozza R.F., Mondelo N., Zanchetta J.R. Interrelationships between densitometric, geometric and mechanical properties of rat femora: inferences concerning mechanical regulation of bone modelling. J. Bone Miner. Res. 1993, 8:1395-1399.
7. Ford J.J., D'Occhio M.J. Differentiation of sexual behaviour in cattle, sheep and swine. J. Anim. Sci. 1989, 67:1816-1823.
8. Gaines A.M., Carroll J.A., Allee G.L. Evaluation of exogenous glucocorticoid injection on preweaning growth performance of neonatal pigs under commercial conditions. J. Anim. Sci. 2004, 82:1241-1245.
9. Holemans K., Aerts L., Van Assche F.A. Fetal growth restriction and consequences for the offspring in animal models. J. Soc. Gynecol. Invest. 2003, 10:392-399.
10. Jepsen K.J., Courtland H.-W., Nadeau J.H. Genetically determined phenotype covariation networks control bone strength. J. Bone Miner. Res. 2010, 25:1581-1593.
11. Laml T., Preyer O., Szulz-Lobmeyr I., Ruecklinger E., Hartmann B.W., Wagenbichler P. Umbilical venous leptin concentration and gender in newborns. Reprod. Sci. 2001, 8:94-97.
12. Manojloviæ-Stojanoski M., Nestoroviæ N., Negiæ N., Filipoviæ B., Šošiæ-Jurjeviæ B., Sekuliæ M., Miloševiæ V. Influence of maternal dexamethasone treatment on morphometric characteristics of pituitary GH cells and body weight in near-term rat fetuses. Folia Histochem. Cytobiol. 2007, 45:51-56.
13. Marshall S., Garvey W.T., Traxinger R.R. New insights into the metabolic regulation of insulin action and insulin resistance: r61e of glucose and amino acids. FASEB J. 1991, 5:3031-3036.
14. Miller S.C., Bowman B.M., Jee W.S. Available animal models of osteopenia-small and large. Bone 1995, 17:117S-123S.
15. Newcomer J.W., Selke G., Melson A.K., Gross J., Vogler G.P., Dagogo-Jack S. Dose-dependent cortisol-induced increases in plasma leptin concentration in healthy humans. Arch. Gen. Psychiatry 1998, 55:995-1000.
16. Newnham J.P., Moss T.J. Antenatal glucocorticoids and growth: single versus multiple doses in animal and human studies. Semin. Neonatol. 2001, 6:285-292.
17. Owen D., Andrews M.H., Matthews S.G. Maternal adversity, glucocorticoids and programming of neuroendocrine function and behavior. Neurosci. Biobehav. Rev. 2005, 29:209-226.
18. Pierzynowski S.G., Sjodin A. Perspectives of glutamine and its derivatives as feed additives for farm animals. J. Anim. Feed Sci. 1998, 7:79-91.
19. Pierzynowski S.G., Valvedre Piedra J.L., Hommel-Hanses T., Studziński T. Glutamine's importance in gut health. Feed Mix 2002, 10:26-29.
20. Pollard J. Prenatal stress effects over two generations in rats. J. Endocrinol. 1986, 109:239-244.
21. Raff H. Neonatal dexamethasone therapy: short- and long-term consequences. Trends Endocrinol. Metab. 2004, 15:352-353.
22. Reed S.J.B., Ware N.G. Quantitative electron microprobe analysis of silicates using energy-dispersive x-ray spectrometry. J. Pet. 1975, 16:499-519.
23. Rodwell V.W. Metabolism of proteins and amino acids. Harper's Illustrated Biochemistry 2003, Lange, Stamford, CT, (Chapter 7). 26th ed. R.K. Murray, D.K. Granner, P.A. Mayes, V.W. Rodwell (Eds.).
24. Seckl J.R. Glucocorticoid programming of the fetus; adult phenotypes and molecular mechanisms. Mol. Cell. Endocrinol. 2001, 185:61-71.
25. Sève B., Ponter A.A. Nutrient-hormone signals regulating muscle protein turnover in pigs. Proc. Nutr. Soc. 1997, 56:565-580.
26. Śliwa E., Dobrowolski P., Piersiak T. Bone development of suckling piglets after prenatal, neonatal or perinatal treatment with dexamethasone. J. Anim. Physiol. Anim. Nutr. 2010, 94:293-306.
27. Śliwa E., Dobrowolski P., Tatara M.R., Piersiak T., Siwicki A., Rokita E. Alpha-ketoglutarate protects the liver of piglets exposed during prenatal life to chronic excess of dexamethasone from metabolic and structural changes. J. Anim. Physiol. Anim. Nutr. 2009, 93:192-202.
28. Śliwa E., Tatara M.R., Nowakowski H., Pierzynowski S.G., Studziński T. Effect of maternal dexamethsone and alpha-ketoglutarate administration on skeletal development during the last three weeks of prenatal life in pigs. J. Mater.-Fetal Neonatal Med. 2006, 19:489-493.
29. Śliwa E., Dobrowolski P. Perinatal programing of skeletal system. J. Pre-Clin. Clin. Res. 2007, 1:111-117.
30. Śliwa E., Kowalik S., Tatara M.R., Studziński T. Effect of maternal administration of dexamethasone during last weeks of pregnancy on foetal skeletal system in pigs. Bull. Vet. Inst. Pulawy 2004, 48:449-452.
31. Tomaszewska E., Dobrowolski P., Puzio I. Postnatal administration of 2-oxoglutaric acid improves the intestinal barrier affected by prenatal action of dexamethasone in pigs. Nutrition 2012, 28:190-196.
32. Weiler H., Paes B., Shas J.K., Atkinson A. Longitudinal assessment of growth and bone mineral accretion in a prematurely born infant treated for chronic lung disease with dexamethasone. Early Hum. Dev. 1997, 47:271-286.
33. Weiler H.A., Kovacs H., Murdock C., Adolphe J., Fitzpatrick-Wong S. Leptin predicts bone and fat mass after accounting for the effects of diet and glucocorticoid treatment in piglets. Exp. Biol. Med. 2002, 227:639-644.
34. Weiler H., Wang Z., Atkinson S. Lean body mass and protein and energy utilization for growth are lower in dexamethasone-treated piglets. Biol. Neonate 1997, 71:53-59.
35. Wu G. Intestinal mucosal amino acids catabolism. J. Nutr. 1998, 128:1249-1252.
36. Wu G. Amino acid metabolism in the small intestine. Trends Comp. Biochem. Physiol. 1998, 4:39-74.